Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

GizmodoPublished May 11, 2026

A startup supported by Mark Zuckerberg has acquired the company that developed Ozempic to advance Parkinson's disease treatment. This move aims to innovate therapies for Parkinson's by leveraging AI technologies.

#ai-startup #mark-zuckerberg #ozempic #parkinson-s-disease

Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

More in Healthcare

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

UK government sets out $800 million for AI security funding